Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD.
Nicholas Alexander KennedySimeng LinJames R GoodhandNeil ChanchlaniBenjamin HamiltonClaire M BewsheaRachel NiceDesmond CheeJ R Fraser CummingsAileen FraserPeter M IrvingNikolaos KamperidisKlaartje B KokChristopher Andrew LambJonathan MacdonaldShameer J MehtaRichard C G PollokTimothy RainePhilip J SmithAjay Mark VermaSimon JochumTimothy James McDonaldShaji SebastianCharlie W LeesNicholas PowellTariq Ahmadnull nullPublished in: Gut (2021)
ISRCTN45176516.